Ashley Watson is vice president and chief ethics and compliance officer at HP, overseeing the strategy and implementation of HP’s ethics and compliance program, including adherence to the Standards of Business Conduct. Her team is also responsible for social and environmental sustainability and compliance, privacy, global records management and the HP Foundation.
Previously, she led the Global Functions legal team responsible for providing legal support to HR, CASS, IT and Corporate Marketing. The Global Functions legal
group, like its functional clients, partners closely with other legal groups to ensure seamless risk assessment and advice.
Before joining HP in December 2008, Watson was Vice President, General Counsel and Corporate Secretary at Attenex, responsible for all company legal matters, including M&A, strategic alliances, IP Policy, risk management and compliance, managing members of the legal department and overseeing outside counsel. She was previously senior litigation Counsel at BellSouth Corporation, responsible for complex litigation.
Watson holds a J.D. degree from the University of Georgia and her undergraduate degree from the University of North Carolina at Chapel Hill.
What is Ashley Watson's net worth?
The estimated net worth of Ashley Watson is at least $2.92 million as of October 31st, 2018. Ms. Watson owns 32,990 shares of Merck & Co., Inc. stock worth more than $2,920,803 as of March 26th. This net worth approximation does not reflect any other investments that Ms. Watson may own. Learn More about Ashley Watson's net worth.
How do I contact Ashley Watson?
The corporate mailing address for Ms. Watson and other Merck & Co., Inc. executives is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. Merck & Co., Inc. can also be reached via phone at (908) 740-4000 and via email at investor_relations@merck.com. Learn More on Ashley Watson's contact information.
Has Ashley Watson been buying or selling shares of Merck & Co., Inc.?
Ashley Watson has not been actively trading shares of Merck & Co., Inc. in the last ninety days. Most recently, Ashley Watson sold 47,036 shares of the business's stock in a transaction on Wednesday, October 31st. The shares were sold at an average price of $74.33, for a transaction totalling $3,496,185.88. Following the completion of the sale, the senior vice president now directly owns 32,990 shares of the company's stock, valued at $2,452,146.70. Learn More on Ashley Watson's trading history.
Who are Merck & Co., Inc.'s active insiders?
Merck & Co., Inc.'s insider roster includes Sanat Chattopadhyay (Insider), Frank Clyburn (EVP), Robert Davis (CFO), Richard Deluca (EVP), Cristal Downing (Insider), Kenneth Frazier (Insider), Julie Gerberding (EVP), Clark Golestani (EVP), Michael Holston (EVP), Rita Karachun (VP), Caroline Litchfield (CFO), Steven Mizell (EVP), Johannes Oosthuizen (Insider), Joseph Romanelli (Insider), Inge Thulin (Director), Ashley Watson (SVP), and Wendell Weeks (Director). Learn More on Merck & Co., Inc.'s active insiders.
Are insiders buying or selling shares of Merck & Co., Inc.?
During the last year, Merck & Co., Inc. insiders bought shares 1 times. They purchased a total of 2,833 shares worth more than $250,012.25. During the last year, insiders at the sold shares 1 times. They sold a total of 2,361 shares worth more than $209,562.36. The most recent insider tranaction occured on February, 6th when Director Inge G Thulin bought 2,833 shares worth more than $250,012.25. Insiders at Merck & Co., Inc. own 0.1% of the company.
Learn More about insider trades at Merck & Co., Inc.. Information on this page was last updated on 2/6/2025.
